Lilla Nagy
Overview
Explore the profile of Lilla Nagy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fonodi M, Nagy L, Boratko A
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 38999976
Tumor angiogenesis, the formation of new blood vessels to support tumor growth and metastasis, is a complex process regulated by a multitude of signaling pathways. Dysregulation of signaling pathways involving...
2.
Nagy L, Rauch B, Szerafin T, Uray K, Toth A, Bai P
Front Cell Dev Biol
. 2022 Sep;
10:979330.
PMID: 36072335
Beige adipocytes play key roles in organismal energy and metabolic balance. In this study, we assessed whether the supplementation of human white adipocytes, differentiated from human adipose tissue-derived stem cells,...
3.
Nagy L, Beke F, Juhasz L, Kovacs T, Juhasz-Toth E, Docsa T, et al.
PLoS One
. 2020 Sep;
15(9):e0236081.
PMID: 32960890
Type 2 diabetes mellitus (T2DM), one of the most common metabolic diseases, is characterized by insulin resistance and inadequate insulin secretion of β cells. Glycogen phosphorylase (GP) is the key...
4.
Lodi M, Priksz D, Fulop G, Bodi B, Gyongyosi A, Nagy L, et al.
J Transl Med
. 2019 Jul;
17(1):229.
PMID: 31324258
Background: Chemotherapy-induced left ventricular dysfunction represents a major clinical problem, which is often only recognised at an advanced stage, when supportive therapy is ineffective. Although an early heart failure treatment...
5.
Nagy L, Rauch B, Balla N, Ujlaki G, Kis G, Abdul-Rahman O, et al.
Biochem Pharmacol
. 2019 Jun;
167:76-85.
PMID: 31251940
Mitochondrial biogenesis is a key feature of energy expenditure and organismal energy balance. Genetic deletion of PARP1 or PARP2 was shown to induce mitochondrial biogenesis and energy expenditure. In line...
6.
Marton J, Fodor T, Nagy L, Vida A, Kis G, Brunyanszki A, et al.
PLoS One
. 2018 Jan;
13(1):e0187789.
PMID: 29293500
Poly(ADP-ribose) polymerase (PARP)10 is a PARP family member that performs mono-ADP-ribosylation of target proteins. Recent studies have linked PARP10 to metabolic processes and metabolic regulators that prompted us to assess...
7.
Nagy L, Marton J, Vida A, Kis G, Bokor E, Kun S, et al.
Br J Pharmacol
. 2017 Apr;
175(2):301-319.
PMID: 28409826
Background And Purpose: Glycogen phosphorylase (GP) is the key enzyme for glycogen degradation. GP inhibitors (GPi-s) are glucose lowering agents that cause the accumulation of glucose in the liver as...
8.
Abdul-Rahman O, Kristof E, Doan-Xuan Q, Vida A, Nagy L, Horvath A, et al.
PLoS One
. 2016 Jun;
11(6):e0157644.
PMID: 27322180
Beige adipocytes are special cells situated in the white adipose tissue. Beige adipocytes, lacking thermogenic cues, morphologically look quite similar to regular white adipocytes, but with a markedly different response...
9.
Nagy B, Woth G, Merei A, Nagy L, Lantos J, Menyhei G, et al.
Indian J Med Res
. 2016 Apr;
143(2):220-6.
PMID: 27121520
Background & Objectives: Ischaemic stroke is a life burdening disease for which carotid endarterectomy (CEA) is considered a gold standard intervention. Pro-inflammatory markers like matrix metalloproteinases (MMPs) and their inhibitors...
10.
Fodor T, Szanto M, Abdul-Rahman O, Nagy L, Der A, Kiss B, et al.
PLoS One
. 2016 Feb;
11(2):e0150232.
PMID: 26919657
Cancer cells are characterized by metabolic alterations, namely, depressed mitochondrial oxidation, enhanced glycolysis and pentose phosphate shunt flux to support rapid cell growth, which is called the Warburg effect. In...